Achondroplasia is the most common skeletal dysplasia. It results in Rhizomelic dwarfism (the dominant feature is proximal (i.e. femoral and humeral) limb shortening). Characterized by disproportionate dwarfism (normal sized torso & short limbs). Results from a defect in endochondral bone formation (cartilage doesn’t convert to bone) - Patients are of normal intelligence with normal motor function.
Achondroplasia

Achondroplasia Treatment Options
Achondroplasia: Medicine Notes
A patient with achondroplasia (dwarfism) before


Achondroplasia Treatment Biomarin
Achondroplasia


Explore the latest trends in the Achondroplasia market, including epidemiology, current treatment landscape, and future growth projections across major global markets. Driven by advancements in genetic therapies, improved diagnosis rates, and rising research investments, the market is evolving rapidly with innovative treatments like CNP analogs and FGFR3-targeted therapies. Discover key companies, emerging pipeline drugs, and opportunities shaping the future of rare skeletal disorder care.
Achondroplasia Treatments Singapore Dwarfism









